EFFECTIVE PORTAL INSULIN DELIVERY WITH ENZYME-PROTECTED CAPSULES IN PANCREATECTOMIZED PIGS

1. Plasma concentrations of insulin, C-peptide, glucagon and glucose were measured in surgically pancreatectomized pigs given insulin into the colon directly and in enteric peptidase-resistant (methacrylic acid copolymer-encapsulated) form. 2. Following introduction of insulin-containing capsules, plasma insulin concentration rose from 2.7 +/- 0.1-mu-U/ml to 110.9 +/- 51.9-mu-U/ml in the portal vein, and from 2.6 +/- 0.1-mu-U/ml to 26.9 +/- 7.3-mu-U/ml in the systemic circulation. Corresponding portal and systemic values after direct (non-encapsulated) insulin instillation were 28.2 +/- 15.9-mu-U/ml to 44.8 +/- 13.0-mu-U/ml and 7.5 +/- 2.6-mu-U/ml to 15.2 +/- 2.5-mu-U/ml respectively. Insulin concentrations peaked at 75 min in the group as a whole and between 60-90 min in individual animals. Absorption was most pronounced in pigs given aprotinin (a trypsin inhibitor) with insulin. 3. Plasma portal vein glucose concentrations fell from 76.2 +/- 8.9 mg/dl to 31.1 +/- 3.2 mg/dl 150 min after encapsulated insulin administration. Corresponding systemic glucose levels were 84.5 +/- 11.0 mg/dl and 37.0 +/- 1.4 mg/dl. 4. Colonic administration of insulin in methacrylic acid coated capsules results in peak portal and systemic insulin levels 60-90 min after administration. Co-administration of aprotinin enhances the fraction of insulin absorbed.